<DOC>
	<DOCNO>NCT00832429</DOCNO>
	<brief_summary>The goal clinical research study use sentinel lymph node ( SLN - lymph node closest primary tumor believe great risk spread disease ) mapping find SLNs biopsy see metastatic disease ( cancer spread ) would otherwise find .</brief_summary>
	<brief_title>Sentinel Lymph Node ( SLN ) Biopsy Sebaceous Gland Carcinoma Eyelid</brief_title>
	<detailed_description>If agree take part study , come clinic 2 different time lymphatic mapping SLN mapping/biopsy . If able become pregnant , blood ( 2 teaspoon ) draw pregnancy test , within 7 day biopsy . To take part study , must pregnant . Lymphatic mapping procedure small amount radioactive substance call Tc99m-Sulfur colloid inject eyelid around tumor ( ) make lymph node visible imaging scan . After Tc99m-Sulfur colloid inject , single photon emission compute tomography/computed tomography ( SPECT/CT ) scan perform . For SLN biopsy procedure , go operate room undergo SLN mapping biopsy general anesthesia . A small amount Tc99m-Sulfur colloid inject eyelid around tumor ( ) , help doctor find possible SLNs . If tumor remove earlier , small amount Tc99m-Sulfur colloid inject eyelid around area earlier tumor site . Then SLN biopsy . To collect SLN biopsy , doctor make small incision tissue lymph node pick Tc99m-Sulfur colloid . The lymph nod remove tested sign metastatic disease . If biopsy show sign metastatic disease , receive standard care metastatic cancer eyelid . You separately consent . Length Study : You continue observe study 5 year biopsy . You come clinic follow-up scan test time . Long-Term Follow-Up : Every 3 month first year biopsy , every 6 month 5 year biopsy , eye exam check status disease . You head neck CT MRI every 6 month first year biopsy make sure disease come back . You chest x-ray 1 year biopsy make sure disease come back . The head neck CT MRI repeat 1 time year 5 year biopsy , well whenever doctor think need . You ultrasound lymph node cheek neck area 1 year primary tumor remove check metastatic disease . This investigational study . The described procedure lymphatic mapping biopsy standard care region body . Lymphatic mapping SLN biopsy eyelid cancer investigational .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Eye Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma , Sebaceous</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>1 . Participant must 18 year age . 2 . Possible suspicious sebaceous gland carcinoma eyelid . 3 . A CXR ( chest xray ) , liver enzymes , head neck CT magnetic resonance imaging ( MRI ) ultrasound negative clinical evidence metastasis . 4 . Patient provide write informed consent . In event nonEnglish speaking participant eligible study , short form ( applicable ) ICD language , utilized complete accordance MDACC Policy Consenting NonEnglish Speaking Participants . 1 ) Pregnant nursing female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sebaceous Gland Carcinoma Eyelid</keyword>
	<keyword>Eyelid Sebaceous Gland Carcinoma</keyword>
	<keyword>Cancer eyelid</keyword>
	<keyword>Eye Cancer</keyword>
	<keyword>Tumors Eye</keyword>
	<keyword>Sentinel Lymph Node Localization Biopsy</keyword>
	<keyword>SLN</keyword>
	<keyword>Metastatic Disease</keyword>
	<keyword>Metastatic Cancer Eyelid</keyword>
	<keyword>Lymphatic Mapping</keyword>
	<keyword>SLN Mapping/Biopsy</keyword>
	<keyword>SLN Biopsy Procedure</keyword>
	<keyword>SLN Biopsy</keyword>
	<keyword>Lymph Nodes</keyword>
	<keyword>Tc99m-Sulfur Colloid</keyword>
	<keyword>Single Photon Emission Computed Tomography</keyword>
	<keyword>Computed Tomography</keyword>
	<keyword>SPECT/CT</keyword>
</DOC>